Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

BACKGROUND: Immune checkpoint inhibitors have dramatically changed lung cancer treatment, demonstrating an overall survival benefit. There are limited data about re-challenge in patients with non-small cell lung cancer. We attempted to address this question for re-challenge of immune checkpoint inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Niki, Maiko, Nakaya, Aya, Kurata, Takayasu, Yoshioka, Hiroshige, Kaneda, Toshihiko, Kibata, Kayoko, Ogata, Makoto, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122346/
https://www.ncbi.nlm.nih.gov/pubmed/30190787
http://dx.doi.org/10.18632/oncotarget.25949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122346/
https://www.ncbi.nlm.nih.gov/pubmed/30190787
http://dx.doi.org/10.18632/oncotarget.25949

Ejemplares similares